BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466-472. [PMID: 18639229 DOI: 10.1016/j.amjsurg.2007.12.057] [Cited by in Crossref: 253] [Cited by in F6Publishing: 254] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, Komaki T, Kagawa K, Yasuda H, Naito Y, Itoh Y. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Sci Rep 2020;10:18758. [PMID: 33127996 DOI: 10.1038/s41598-020-75745-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
2 Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G, Knox JJ, Tran B, Tannock IF, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124. [PMID: 24875653 DOI: 10.1093/jnci/dju124] [Cited by in Crossref: 1177] [Cited by in F6Publishing: 1247] [Article Influence: 147.1] [Reference Citation Analysis]
3 Spolverato G, Maqsood H, Kim Y, Margonis G, Luo T, Ejaz A, Pawlik TM. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. J Surg Oncol 2015;111:868-74. [PMID: 25865111 DOI: 10.1002/jso.23900] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
4 Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. Mol Clin Oncol 2017;6:566-74. [PMID: 28413670 DOI: 10.3892/mco.2017.1166] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
5 Paik KY, Lee IK, Lee YS, Sung NY, Kwon TS. Clinical implications of systemic inflammatory response markers as independent prognostic factors in colorectal cancer patients. Cancer Res Treat. 2014;46:65-73. [PMID: 24520225 DOI: 10.4143/crt.2014.46.1.65] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
6 Junare PR, Debnath P, Nair S, Chandnani S, Udgirkar S, Thange R, Jain S, Deshmukh R, Debnath P, Rathi P, Contractor Q, Deshpande A. Complete hemogram: simple and cost-effective in staging and predicting outcome in acute pancreatitis. Wien Klin Wochenschr 2021;133:661-8. [PMID: 33620577 DOI: 10.1007/s00508-021-01821-2] [Reference Citation Analysis]
7 Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol 2016;51:153-61. [PMID: 26187429 DOI: 10.1007/s00535-015-1103-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
8 Kim M, Moon KC, Choi WS, Jeong CW, Kwak C, Kim HH, Ku JH. Prognostic value of systemic inflammatory responses in patients with upper urinary tract urothelial carcinoma. World J Urol 2015;33:1439-57. [PMID: 25600022 DOI: 10.1007/s00345-015-1484-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
9 Taşoğlu Ö, Şahin A, Karataş G, Koyuncu E, Taşoğlu İ, Tecimel O, Özgirgin N. Blood mean platelet volume and platelet lymphocyte ratio as new predictors of hip osteoarthritis severity. Medicine (Baltimore) 2017;96:e6073. [PMID: 28178164 DOI: 10.1097/MD.0000000000006073] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
10 Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C, Rodríguez CM, Martínez L, Sánchez-Lara K. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010;10:50. [PMID: 20170547 DOI: 10.1186/1471-2407-10-50] [Cited by in Crossref: 155] [Cited by in F6Publishing: 154] [Article Influence: 12.9] [Reference Citation Analysis]
11 Zheng BH, Yang LX, Sun QM, Fan HK, Duan M, Shi JY, Wang XY, Zhou J, Fan J, Ma ZY, Gao Q. A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma. Clin Transl Gastroenterol 2017;8:e118. [PMID: 28981082 DOI: 10.1038/ctg.2017.45] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
12 Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu FG, Vashist YK, Izbicki JR, Bogoevski D. Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment. Surgery 2016;159:1548-56. [DOI: 10.1016/j.surg.2016.01.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
13 Yang H, Zhu L, Wang S, Lang J, Xu T. Noninvasive Diagnosis of Moderate to Severe Endometriosis: The Platelet-Lymphocyte Ratio Cannot Be a Neoadjuvant Biomarker for Serum Cancer Antigen 125. Journal of Minimally Invasive Gynecology 2015;22:373-7. [DOI: 10.1016/j.jmig.2013.06.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
14 Watanabe Y, Niina Y, Nishihara K, Okayama T, Tamiya S, Nakano T. Neutrophil-to-lymphocyte ratio and mural nodule height as predictive factors for malignant intraductal papillary mucinous neoplasms. Acta Chir Belg 2018;118:239-45. [PMID: 29334845 DOI: 10.1080/00015458.2018.1427329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Yutong H, Xiaoli X, Shumei L, Shan S, Di L, Baoen S. Increased Neutrophil-Lymphocyte Ratio Is a Poor Prognostic Factor in Patients with Esophageal Cancer in a High Incidence Area in China. Arch Med Res 2015;46:557-63. [PMID: 26385485 DOI: 10.1016/j.arcmed.2015.09.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
16 Pan QX, Su ZJ, Zhang JH, Wang CR, Ke SY. A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther. 2015;8:1375-1385. [PMID: 26124667 DOI: 10.2147/ott.s82437] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
17 Matsumoto S, Nakayama M, Gosho M, Nishimura B, Takahashi K, Yoshimura T, Senarita M, Ohara H, Akizuki H, Wada T, Tabuchi K. Inflammation-Based Score (Combination of Platelet Count and Neutrophil-to-Lymphocyte Ratio) Predicts Pharyngocutaneous Fistula After Total Laryngectomy. Laryngoscope 2021. [PMID: 34870336 DOI: 10.1002/lary.29970] [Reference Citation Analysis]
18 Tustumi F, Takeda FR, Viyuela MS, da Cruz Junior JB, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer. J Surg Oncol 2020;121:784-94. [PMID: 31762058 DOI: 10.1002/jso.25778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Saito H, Noji T, Okamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery 2016;159:842-51. [DOI: 10.1016/j.surg.2015.10.027] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
20 Uzun F, Erturk M, Cakmak HA, Kalkan AK, Akturk IF, Yalcin AA, Uygur B, Bulut U, Oz K. Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej 2017;13:32-8. [PMID: 28344615 DOI: 10.5114/aic.2017.66184] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
21 Toya K, Tomimaru Y, Kobayashi S, Sasaki K, Iwagami Y, Yamada D, Noda T, Takahashi H, Doki Y, Eguchi H. Preoperative neutrophil‐to‐lymphocyte ratio predicts healing time for postoperative pancreatic fistula after distal pancreatectomy. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12510] [Reference Citation Analysis]
22 Okadome K, Baba Y, Yagi T, Kiyozumi Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Baba H. Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer. Ann Surg 2020;271:693-700. [PMID: 30308614 DOI: 10.1097/SLA.0000000000002985] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
23 Lee BM, Chung SY, Chang JS, Lee KJ, Seong J. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy. Gut Liver 2018;12:342-52. [PMID: 29409306 DOI: 10.5009/gnl17216] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
24 Li H, Tian X, Xu Y, Pan Y, Huang Y, Zhou D, Song Z. Prognostic value of pre-treatment peripheral blood markers in pancreatic ductal adenocarcinoma and their association with S100A4 expression in tumor tissue. Oncol Lett 2019;18:4523-34. [PMID: 31611961 DOI: 10.3892/ol.2019.10809] [Reference Citation Analysis]
25 Ye S, Bai L. Comparison and validation of the value of preoperative inflammation marker-based prognostic scores in resectable pancreatic ductal adenocarcinoma. Cancer Manag Res 2018;10:3405-17. [PMID: 30237742 DOI: 10.2147/CMAR.S173444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Kim WJ, Lim TW, Park PJ, Choi SB, Kim WB. Prognostic impact of the combination of the neutrophil-to-lymphocyte ratio and serum carbohydrate antigen 19-9 in patients with pancreas head cancer. ANZ J Surg 2019;89:E302-7. [PMID: 30895709 DOI: 10.1111/ans.15029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Szkandera J, Gerger A, Liegl-atzwanger B, Absenger G, Stotz M, Friesenbichler J, Trajanoski S, Stojakovic T, Eberhard K, Leithner A, Pichler M. The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas: Lymphocyte/monocyte ratio and clinical outcome in soft tissue sarcoma patients. Int J Cancer 2014;135:362-70. [DOI: 10.1002/ijc.28677] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 12.1] [Reference Citation Analysis]
28 Nayan M, Richard PO, Jewett MA, Kachura JR, Evans A, Hamilton RJ, Finelli A. Hematologic Parameters to Predict Small Renal Mass Biopsy Pathology. Clinical Genitourinary Cancer 2016;14:226-30. [DOI: 10.1016/j.clgc.2015.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
29 Song A, Eo W, Lee S. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. World J Gastroenterol 2015; 21(43): 12410-12420 [PMID: 26604648 DOI: 10.3748/wjg.v21.i43.12410] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
30 Tokunaga R, Sakamoto Y, Nakagawa S, Izumi D, Kosumi K, Taki K, Higashi T, Miyata T, Miyamoto Y, Yoshida N, Baba H. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. Int J Clin Oncol 2017;22:740-8. [PMID: 28213742 DOI: 10.1007/s10147-017-1102-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
31 Wang J, Qu J, Li Z, Che X, Liu J, Teng Y, Jin B, Zhao M, Liu Y, Qu X. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer. J Clin Lab Anal 2018;32. [PMID: 28238215 DOI: 10.1002/jcla.22185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
32 Kishi T, Nakamura A, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Kodama Y, Takaori K, Mizowaki T, Hiraoka M. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pancreatology 2015;15:694-700. [DOI: 10.1016/j.pan.2015.09.016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
33 Wang DS, Ren C, Qiu MZ, Luo HY, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol. 2012;33:749-756. [PMID: 22198641 DOI: 10.1007/s13277-011-0285-z] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 6.4] [Reference Citation Analysis]
34 Kawakita Y, Motoyama S, Sato Y, Wakita A, Nagaki Y, Imai K, Minamiya Y. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy. World J Surg 2020;44:1559-68. [PMID: 31907570 DOI: 10.1007/s00268-019-05344-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Zhai G, Wang J, Liu Y, Zhou Y. Platelet-lymphocyte ratio as a new predictor of in-hospital mortality in cardiac intensive care unit patients. Sci Rep 2021;11:23578. [PMID: 34880259 DOI: 10.1038/s41598-021-02686-1] [Reference Citation Analysis]
36 Miyamoto R, Oda T, Hashimoto S, Kurokawa T, Kohno K, Akashi Y, Ohara Y, Yamada K, Enomoto T, Ohkohchi N. Platelet × CRP Multiplier Value as an Indicator of Poor Prognosis in Patients With Resectable Pancreatic Cancer. Pancreas 2017;46:35-41. [DOI: 10.1097/mpa.0000000000000697] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
37 Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA. Preoperative Neutrophil-to-Lymphocyte Ratio is a Better Prognostic Serum Biomarker than Platelet-to-Lymphocyte Ratio in Patients Undergoing Resection for Nonmetastatic Colorectal Cancer. Ann Surg Oncol. 2015;22 Suppl 3:S603-S613. [PMID: 25900206 DOI: 10.1245/s10434-015-4571-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
38 Miglani RK, Bhateja N, Bhat RS, Kumar KV. Diagnostic Role of Platelet Lymphocyte Ratio(PLR) in Pancreatic Head Masses. Indian J Surg 2013;75:4-9. [PMID: 24426375 DOI: 10.1007/s12262-012-0443-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
39 Song DH, Cho IK, Shin DW, Lee JC, Cho JY, Yoon YS, Hwang JH, Han HS, Kim J. The clinical significance of preoperative C-reactive protein/albumin ratio in patients with resected extrahepatic bile duct cancer. Surg Today 2021;51:978-85. [PMID: 33387024 DOI: 10.1007/s00595-020-02188-z] [Reference Citation Analysis]
40 Xu Z, Xu W, Cheng H, Shen W, Ying J, Cheng F, Xu W. The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis. PLoS One 2016;11:e0163719. [PMID: 27684077 DOI: 10.1371/journal.pone.0163719] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
41 Bilici A. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World J Gastroenterol 2014; 20(31): 10802-10812 [PMID: 25152583 DOI: 10.3748/wjg.v20.i31.10802] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 62] [Article Influence: 8.0] [Reference Citation Analysis]
42 Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499-503. [PMID: 21775277 DOI: 10.1007/s12094-011-0687-9] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 13.5] [Reference Citation Analysis]
43 Miura T, Hirano S, Nakamura T, Tanaka E, Shichinohe T, Tsuchikawa T, Kato K, Matsumoto J, Kondo S. A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: A retrospective cohort study. Surgery 2014;155:457-67. [DOI: 10.1016/j.surg.2013.10.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
44 Yao ZW, Zhao BC, Yang X, Lei SH, Jiang YM, Liu KX. Relationships of sleep disturbance, intestinal microbiota, and postoperative pain in breast cancer patients: a prospective observational study. Sleep Breath 2021;25:1655-64. [PMID: 33211236 DOI: 10.1007/s11325-020-02246-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Li X, Chen ZH, Xing YF, Wang TT, Wu DH, Wen JY, Chen J, Lin Q, Dong M, Wei L. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumour Biol. 2015;36:2263-2269. [PMID: 25409616 DOI: 10.1007/s13277-014-2833-9] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
46 Hao X, Wei Y, Wei X, Zhou L, Wei Q, Zhang Y, Huang W, Feng R. Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget 2017;8:76740-8. [PMID: 29100345 DOI: 10.18632/oncotarget.20832] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
47 Ertas IE, Gungorduk K, Akman L, Ozdemir A, Terek MC, Ozsaran A, Sanci M, Dikmen Y. Can preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios be used as predictive markers for lymph node metastasis in squamous cell carcinoma of the vulva? Eur J Obstet Gynecol Reprod Biol 2013;171:138-42. [PMID: 23992992 DOI: 10.1016/j.ejogrb.2013.08.023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
48 Azab B, Shah N, Akerman M, Mcginn JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326-34. [DOI: 10.1007/s11239-012-0718-6] [Cited by in Crossref: 143] [Cited by in F6Publishing: 151] [Article Influence: 14.3] [Reference Citation Analysis]
49 Watanabe J, Otani S, Sakamoto T, Arai Y, Hanaki T, Amisaki M, Tokuyasu N, Honjo S, Ikeguchi M. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer. Surg Today 2016;46:1258-67. [DOI: 10.1007/s00595-016-1308-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
50 Langsenlehner T, Pichler M, Thurner EM, Krenn-Pilko S, Stojakovic T, Gerger A, Langsenlehner U. Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy. Urol Oncol 2015;33:201.e9-16. [PMID: 25769845 DOI: 10.1016/j.urolonc.2015.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
51 Eo WK, Jeong DW, Chang HJ, Won KY, Choi SI, Kim SH, Chun SW, Oh YL, Lee TH, Kim YO, Kim KH, Ji YI, Kim A, Kim HY. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer. World J Gastroenterol 2015; 21(9): 2668-2676 [PMID: 25759535 DOI: 10.3748/wjg.v21.i9.2668] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
52 Wang H, Ding Y, Li N, Wu L, Gao Y, Xiao C, Jiang H, Zheng Y, Mao C, Deng J, Wang H, Xu N. Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer. Front Oncol 2020;10:841. [PMID: 32637353 DOI: 10.3389/fonc.2020.00841] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
53 Maeda K, Shibutani M, Otani H, Nagahara H, Ikeya T, Iseki Y, Tanaka H, Muguruma K, Hirakawa K. Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol 2015; 7(8): 111-117 [PMID: 26306143 DOI: 10.4251/wjgo.v7.i8.111] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
54 Utsumi M, Kitada K, Tokunaga N, Kato T, Narusaka T, Hamano R, Miyasou H, Tsunemitsu Y, Otsuka S, Inagaki M. A combined prediction model for biliary tract cancer using the prognostic nutritional index and pathological findings: a single-center retrospective study. BMC Gastroenterol 2021;21:375. [PMID: 34645392 DOI: 10.1186/s12876-021-01957-5] [Reference Citation Analysis]
55 Li Y, Zhao Y, Feng L, Guo R. Comparison of the prognostic values of inflammation markers in patients with acute pancreatitis: a retrospective cohort study. BMJ Open. 2017;7:e013206. [PMID: 28348184 DOI: 10.1136/bmjopen-2016-013206] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
56 Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer Med. 2014;3:406-415. [PMID: 24519894 DOI: 10.1002/cam4.204] [Cited by in Crossref: 74] [Cited by in F6Publishing: 79] [Article Influence: 9.3] [Reference Citation Analysis]
57 Ahmad J, Grimes N, Farid S, Morris-Stiff G. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Hepatobiliary Pancreat Dis Int 2014;13:474-81. [PMID: 25308357 DOI: 10.1016/s1499-3872(14)60284-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
58 Müller L, Hahn F, Mähringer-Kunz A, Stoehr F, Gairing SJ, Michel M, Foerster F, Weinmann A, Galle PR, Mittler J, Pinto Dos Santos D, Pitton MB, Düber C, Kloeckner R. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index. Cancers (Basel) 2021;13:5018. [PMID: 34638502 DOI: 10.3390/cancers13195018] [Reference Citation Analysis]
59 Aurello P, Tierno SM, Berardi G, Tomassini F, Magistri P, D'Angelo F, Ramacciato G. Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer. Ann Surg Oncol 2014;21:1998-2004. [PMID: 24515568 DOI: 10.1245/s10434-014-3533-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
60 Abdelmalak R, Lythgoe MP, Evans J, Flynn M, Waters J, Webb A, Pinato DJ, Sharma R. Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia. Cancers (Basel) 2021;13:4232. [PMID: 34439386 DOI: 10.3390/cancers13164232] [Reference Citation Analysis]
61 Matsubara D, Arita T, Nakanishi M, Kuriu Y, Murayama Y, Kudou M, Shoda K, Kosuga T, Konishi H, Morimura R, Shiozaki A, Ikoma H, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Preoperative inflammatory response as prognostic factor of patients with colon cancer. Langenbecks Arch Surg 2019;404:731-41. [PMID: 31468113 DOI: 10.1007/s00423-019-01811-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zager Y, Hoffman A, Dreznik Y, Jacoby H, Cordoba M, Horesh N, Nevler A, Gutman M, Berger Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer: The prognostic impact of baseline neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios. Surg Oncol 2020;35:321-7. [PMID: 32977104 DOI: 10.1016/j.suronc.2020.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Seretis C, Seretis F, Lagoudianakis E, Politou M, Gemenetzis G, Salemis NS. Enhancing the accuracy of platelet to lymphocyte ratio after adjustment for large platelet count: a pilot study in breast cancer patients. Int J Surg Oncol 2012;2012:653608. [PMID: 23304480 DOI: 10.1155/2012/653608] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.2] [Reference Citation Analysis]
64 Tustumi F, Takeda FR, Brandão AAGS, Sallum RAA, Ribeiro Junior U, Cecconello I. LYMPHOCYTE COUNT AND PLATELET VOLUME PREDICTS POSTOPERATIVE COMPLICATIONS IN ESOPHAGECTOMY FOR CANCER: A COHORT STUDY. Arq Gastroenterol 2019;56:377-85. [PMID: 31618397 DOI: 10.1590/S0004-2803.201900000-70] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, Siedlar M, Kulig J. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer. Ann Surg Oncol 2017;24:808-15. [PMID: 27770341 DOI: 10.1245/s10434-016-5634-0] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
66 Shao N, Cai Q. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer. Clin Transl Oncol 2015;17:772-8. [PMID: 26243392 DOI: 10.1007/s12094-015-1289-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
67 Onoe S, Maeda A, Takayama Y, Fukami Y, Takahashi T, Uji M, Kaneoka Y. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma. Med Princ Pract 2019;28:517-25. [PMID: 31104057 DOI: 10.1159/000501017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
68 Kasuga J, Kawahara T, Takamoto D, Fukui S, Tokita T, Tadenuma T, Narahara M, Fusayasu S, Terao H, Izumi K, Ito H, Hattori Y, Teranishi J, Sasaki T, Makiyama K, Miyoshi Y, Yao M, Yumura Y, Miyamoto H, Uemura H. Increased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancer. BMC Cancer 2016;16:396. [PMID: 27386948 DOI: 10.1186/s12885-016-2443-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
69 Białas AJ, Pedone C, Piotrowski WJ, Antonelli Incalzi R. Platelet distribution width as a prognostic factor in patients with COPD - pilot study. Int J Chron Obstruct Pulmon Dis 2017;12:2261-7. [PMID: 28814854 DOI: 10.2147/COPD.S131868] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
70 İlhan M, İlhan G, Gök AF, Bademler S, Verit Atmaca F, Ertekin C. Evaluation of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and red blood cell distribution width-platelet ratio as early predictor of acute pancreatitis in pregnancy. J Matern Fetal Neonatal Med 2016;29:1476-80. [PMID: 26043647 DOI: 10.3109/14767058.2015.1051026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
71 He C, Lu Y, Wang B, He J, Liu H, Zhang X. Development and Validation of a Nomogram for Preoperative Prediction of Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma and Type 2 Diabetes Mellitus. Cancer Manag Res 2021;13:2499-513. [PMID: 33762845 DOI: 10.2147/CMAR.S300264] [Reference Citation Analysis]
72 Zhang LX, Lv Y, Xu AM, Wang HZ. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma. BMC Cancer 2019;19:841. [PMID: 31455253 DOI: 10.1186/s12885-019-6011-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
73 Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149-163. [PMID: 20021215 DOI: 10.2217/fon.09.136] [Cited by in Crossref: 525] [Cited by in F6Publishing: 532] [Article Influence: 43.8] [Reference Citation Analysis]
74 Topkan E, Mertsoylu H, Ozdemir Y, Sezer A, Kucuk A, Besen AA, Ozyilkan O, Selek U. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy. Cancer Manag Res 2019;11:8807-15. [PMID: 31632140 DOI: 10.2147/CMAR.S222297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
75 Nakayama M, Gosho M, Hirose Y, Nishimura B, Tanaka S, Tabuchi K, Okubo H, Wada T, Hara A. Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer. Head Neck 2018;40:1138-46. [PMID: 29385295 DOI: 10.1002/hed.25085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
76 Powell AGMT, Parkinson D, Patel N, Chan D, Christian A, Lewis WG. Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer. J Gastrointest Surg 2018;22:595-605. [PMID: 29234999 DOI: 10.1007/s11605-017-3597-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
77 Zhu GS, Tian SB, Wang H, Ma MG, Liu Y, Du HS, Long YP. Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Cannot Predict Lymph Node Metastasis and Prognosis in Patients with Early Gastric Cancer: a Single Institution Investigation in China. Curr Med Sci. 2018;38:78-84. [PMID: 30074155 DOI: 10.1007/s11596-018-1849-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
78 Sun KY, Xu JB, Chen SL, Yuan YJ, Wu H, Peng JJ, Chen CQ, Guo P, Hao YT, He YL. Novel immunological and nutritional-based prognostic index for gastric cancer. World J Gastroenterol 2015; 21(19): 5961-5971 [PMID: 26019461 DOI: 10.3748/wjg.v21.i19.5961] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
79 Lu J, Cao LL, Zheng CH, Li P, Xie JW, Wang JB, Lin JX, Chen QY, Lin M, Tu RH, Huang CM. The Preoperative Frailty Versus Inflammation-Based Prognostic Score: Which is Better as an Objective Predictor for Gastric Cancer Patients 80 Years and Older? Ann Surg Oncol 2017;24:754-62. [PMID: 27807726 DOI: 10.1245/s10434-016-5656-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
80 Pointer DT Jr, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, Schell MJ, Hodul PJ, Pimiento JM, Fleming JB, Malafa MP. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. BMC Cancer 2020;20:750. [PMID: 32782024 DOI: 10.1186/s12885-020-07182-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
81 Kawahara T, Furuya K, Nakamura M, Sakamaki K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, Makiyama K, Nakaigawa N, Yamanaka T, Miyamoto H, Yao M, Uemura H. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy. BMC Cancer 2016;16:185. [PMID: 26944862 DOI: 10.1186/s12885-016-2219-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
82 Azab B, Shah N, Radbel J, Tan P, Bhatt V, Vonfrolio S, Habeshy A, Picon A, Bloom S. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013;30:432. [PMID: 23283648 DOI: 10.1007/s12032-012-0432-4] [Cited by in Crossref: 137] [Cited by in F6Publishing: 144] [Article Influence: 15.2] [Reference Citation Analysis]
83 Kato A, Tsuji T, Sakao Y, Ohashi N, Yasuda H, Fujimoto T, Takita T, Furuhashi M, Kumagai H. A comparison of systemic inflammation-based prognostic scores in patients on regular hemodialysis. Nephron Extra 2013;3:91-100. [PMID: 24403910 DOI: 10.1159/000355148] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
84 Jeon BH, Shin US, Moon SM, Choi JI, Kim M, Kim KH, Sung S. Neutrophil to Lymphocyte Ratio: A Predictive Marker for Treatment Outcomes in Patients With Rectal Cancer Who Underwent Neoadjuvant Chemoradiation Followed by Surgery. Ann Coloproctol 2019;35:100-6. [DOI: 10.3393/ac.2018.10.01] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
85 Liu H, Wu Y, Wang Z, Yao Y, Chen F, Zhang H, Wang Y, Song Y. Pretreatment platelet-to-lymphocyte ratio (PLR) as a predictor of response to first-line platinum-based chemotherapy and prognosis for patients with non-small cell lung cancer. J Thorac Dis 2013;5:783-9. [PMID: 24409356 DOI: 10.3978/j.issn.2072-1439.2013.12.34] [Cited by in F6Publishing: 37] [Reference Citation Analysis]
86 Sato Y, Gonda K, Harada M, Tanisaka Y, Arai S, Mashimo Y, Iwano H, Sato H, Ryozawa S, Takahashi T, Sakuramoto S, Shibata M. Increased neutrophil-to-lymphocyte ratio is a novel marker for nutrition, inflammation and chemotherapy outcome in patients with locally advanced and metastatic esophageal squamous cell carcinoma. Biomed Rep 2017;7:79-84. [PMID: 28685065 DOI: 10.3892/br.2017.924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
87 Kos M, Hocazade C, Kos FT, Uncu D, Karakas E, Dogan M, Uncu HG, Yildirim N, Zengin N. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer. Wien Klin Wochenschr 2016;128:635-40. [PMID: 25720573 DOI: 10.1007/s00508-015-0724-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
88 Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH, Kim HJ. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350. [PMID: 23876227 DOI: 10.1186/1471-2407-13-350] [Cited by in Crossref: 158] [Cited by in F6Publishing: 178] [Article Influence: 17.6] [Reference Citation Analysis]
89 Oh HH, Joo YE. Novel biomarkers for the diagnosis and prognosis of colorectal cancer. Intest Res 2020;18:168-83. [PMID: 31766836 DOI: 10.5217/ir.2019.00080] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
90 Garcea G, Ladwa N, Neal CP, Metcalfe MS, Dennison AR, Berry DP. Preoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinoma. World J Surg. 2011;35:868-872. [PMID: 21312035 DOI: 10.1007/s00268-011-0984-z] [Cited by in Crossref: 133] [Cited by in F6Publishing: 132] [Article Influence: 12.1] [Reference Citation Analysis]
91 Kim SH, Lee HW, Go SI, Lee SI, Lee GW. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer. Oncotarget 2016;7:36198-206. [PMID: 27105529 DOI: 10.18632/oncotarget.8809] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
92 Hong C, Wei Y, Jiang J, Zhao C, Liang G, Wang G, Yang H. Associations between lifestyles and neutrophil-lymphocyte and platelet-lymphocyte ratios in colorectal cancer. Asia Pac J Clin Oncol. 2014;10:168-174. [PMID: 23714008 DOI: 10.1111/ajco.12080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
93 Gürsoy OM, Karakoyun S, Kalçik M, Gökdeniz T, Yesin M, Gündüz S, Astarcioğlu MA, Ozkan M. Usefulness of novel hematologic inflammatory parameters to predict prosthetic mitral valve thrombosis. Am J Cardiol 2014;113:860-4. [PMID: 24411287 DOI: 10.1016/j.amjcard.2013.11.029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
94 Hu P, Liu Q, Deng G, Zhang J, Liang N, Xie J, Zhang J. Radiosensitivity nomogram based on circulating neutrophils in thoracic cancer. Future Oncol 2019;15:727-37. [PMID: 30693787 DOI: 10.2217/fon-2018-0398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
95 Okuno M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T, Yamaguchi J, Nagino M. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2016;23:636-42. [PMID: 27474781 DOI: 10.1002/jhbp.386] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
96 Hyder J, Boggs DH, Hanna A, Suntharalingam M, Chuong MD. Changes in neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios during chemoradiation predict for survival and pathologic complete response in trimodality esophageal cancer patients. J Gastrointest Oncol 2016;7:189-95. [PMID: 27034785 DOI: 10.3978/j.issn.2078-6891.2015.080] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
97 Hua X, Chen J, Wu Y, Sha J, Han S, Zhu X. Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis. World J Surg Oncol 2019;17:177. [PMID: 31677642 DOI: 10.1186/s12957-019-1725-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
98 Haksoyler V, Topkan E. Prognostic Utility of Prechemoradiotherapy Albumin-to-Alkaline Phosphatase Ratio in Unresectable Locally Advanced Pancreatic Carcinoma Patients. Gastroenterol Res Pract 2021;2021:6647145. [PMID: 33927759 DOI: 10.1155/2021/6647145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
99 Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Sci Rep. 2017;7:16717. [PMID: 29196718 DOI: 10.1038/s41598-017-16955-5] [Cited by in Crossref: 112] [Cited by in F6Publishing: 111] [Article Influence: 22.4] [Reference Citation Analysis]
100 Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
101 Zhou B, Zhan C, Wu J, Liu J, Zhou J, Zheng S. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors. Med Sci Monit 2017;23:5574-88. [PMID: 29168979 DOI: 10.12659/msm.907182] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
102 Xiao Y, Xie Z, Shao Z, Chen W, Xie H, Qin G, Zhao N. Prognostic value of postdiagnostic inflammation-based scores in short-term overall survival of advanced pancreatic ductal adenocarcinoma patients. Medicine (Baltimore) 2017;96:e9247. [PMID: 29390358 DOI: 10.1097/MD.0000000000009247] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
103 Verit FF, Cetin O, Yildirim O, Keskin S, Yucel O, Yalcinkaya S. Neutrophil to lymphocyte ratio is superior to platelet to lymphocyte ratio as an early predictor of moderate/severe ovarian hyperstimulation syndrome. Journal of Obstetrics and Gynaecology 2014;34:639-43. [DOI: 10.3109/01443615.2014.920792] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
104 Pappalardo A, Giunta EF, Tirino G, Pompella L, Federico P, Daniele B, De Vita F, Petrillo A. Adjuvant Treatment in Pancreatic Cancer: Shaping the Future of the Curative Setting. Front Oncol 2021;11:695627. [PMID: 34485130 DOI: 10.3389/fonc.2021.695627] [Reference Citation Analysis]
105 Bahig H, Taussky D, Delouya G, Nadiri A, Gagnon-Jacques A, Bodson-Clermont P, Soulieres D. Neutrophil count is associated with survival in localized prostate cancer. BMC Cancer 2015;15:594. [PMID: 26292807 DOI: 10.1186/s12885-015-1599-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
106 Moore MM, Chua W, Charles KA, Clarke SJ. Inflammation and cancer: causes and consequences. Clin Pharmacol Ther. 2010;87:504-508. [PMID: 20147899 DOI: 10.1038/clpt.2009.254] [Cited by in Crossref: 126] [Cited by in F6Publishing: 124] [Article Influence: 10.5] [Reference Citation Analysis]
107 Jiang R, Zou X, Hu W, Fan Y, Yan Y, Zhang M, You R, Sun R, Luo D, Chen Q, Huang P, Hua Y, Guo L, Chen M. The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients. Tumor Biol 2015;36:7775-87. [DOI: 10.1007/s13277-015-3505-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
108 Neofytou K, Smyth EC, Giakoustidis A, Khan AZ, Cunningham D, Mudan S. Elevated platelet to lymphocyte ratio predicts poor prognosis after hepatectomy for liver-only colorectal metastases, and it is superior to neutrophil to lymphocyte ratio as an adverse prognostic factor. Med Oncol 2014;31:239. [PMID: 25218270 DOI: 10.1007/s12032-014-0239-6] [Cited by in Crossref: 56] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
109 Ida M, Takeshita Y, Kawaguchi M. Preoperative serum biomarkers in the prediction of postoperative delirium following abdominal surgery. Geriatr Gerontol Int 2020;20:1208-12. [PMID: 33084189 DOI: 10.1111/ggi.14066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
110 Teramura K, Noji T, Nakamura T, Asano T, Tanaka K, Nakanishi Y, Tsuchikawa T, Okamura K, Shichinohe T, Hirano S. Preoperative diagnosis of portal vein invasion in pancreatic head cancer: appropriate indications for concomitant portal vein resection: Preoperative diagnosis of portal vein invasion in pancreatic head cancer: appropriate indications for concomitant portal vein resection. J Hepatobiliary Pancreat Sci 2016;23:643-9. [DOI: 10.1002/jhbp.387] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
111 Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Kornprat P, Stojakovic T, Avian A, Gerger A. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg 2014;208:210-4. [PMID: 24581872 DOI: 10.1016/j.amjsurg.2013.10.030] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
112 Kawahara T, Yokomizo Y, Ito Y, Ito H, Ishiguro H, Teranishi J, Makiyama K, Miyoshi Y, Miyamoto H, Yao M, Uemura H. Pretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancer. BMC Cancer 2016;16:111. [PMID: 26883640 DOI: 10.1186/s12885-016-2134-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
113 Zhou D, Liang J, Xu LI, He F, Zhou Z, Zhang Y, Chen M. Derived neutrophil to lymphocyte ratio predicts prognosis for patients with HBV-associated hepatocellular carcinoma following transarterial chemoembolization. Oncol Lett 2016;11:2987-94. [PMID: 27123051 DOI: 10.3892/ol.2016.4359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
114 Chua W, Kho PS, Moore MM, Charles KA, Clarke SJ. Clinical, laboratory and molecular factors predicting chemotherapy efficacy and toxicity in colorectal cancer. Crit Rev Oncol Hematol. 2011;79:224-250. [PMID: 20719530 DOI: 10.1016/j.critrevonc.2010.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
115 Kang MH, Go SI, Song HN, Lee A, Kim SH, Kang JH, Jeong BK, Kang KM, Ling H, Lee GW. The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer. Br J Cancer 2014;111:452-60. [PMID: 24921916 DOI: 10.1038/bjc.2014.317] [Cited by in Crossref: 101] [Cited by in F6Publishing: 119] [Article Influence: 12.6] [Reference Citation Analysis]
116 Pacheco-Barcia V, Mondéjar Solís R, France T, Asselah J, Donnay O, Zogopoulos G, Bouganim N, Guo K, Rogado J, Martin E, Alcindor T, Colomer R. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology 2020;20:254-64. [PMID: 31866391 DOI: 10.1016/j.pan.2019.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
117 Chen W, Chen K, Xu Z, Hu Y, Liu Y, Liu W, Hu X, Ye T, Hong J, Zhu H, Shen F. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations. Diabetes Metab Syndr Obes 2021;14:821-9. [PMID: 33658817 DOI: 10.2147/DMSO.S284583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Bugada D, Allegri M, Lavand'homme P, De Kock M, Fanelli G. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int 2014;2014:142425. [PMID: 24877056 DOI: 10.1155/2014/142425] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
119 Yüksel M, Yıldız A, Oylumlu M, Akyüz A, Aydın M, Kaya H, Acet H, Polat N, Bilik MZ, Alan S. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2015;15:640-7. [PMID: 25550173 DOI: 10.5152/akd.2014.5565] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
120 Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, Kim SJ, Lee SH. Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion. PLoS One 2018;13:e0200341. [PMID: 30005083 DOI: 10.1371/journal.pone.0200341] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
121 Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, Wagner TH, Leppert JT, Mallick P, McCarty OJT. The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis. Front Oncol 2018;8:78. [PMID: 29619344 DOI: 10.3389/fonc.2018.00078] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
122 Markus M, Abendroth A, Noureddine R, Paul A, Breitenbuecher S, Virchow I, Schmid KW, Markus P, Schumacher B, Wiesweg M, Wendling J, Mende B, Siveke JT, Schuler M, Kasper S. Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapy. J Cancer Res Clin Oncol 2021;147:579-91. [PMID: 32839836 DOI: 10.1007/s00432-020-03361-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Farhan-Alanie OM, McMahon J, McMillan DC. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2015;53:126-131. [PMID: 25440150 DOI: 10.1016/j.bjoms.2014.10.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
124 Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218-230. [PMID: 23602134 DOI: 10.1016/j.critrevonc.2013.03.010] [Cited by in Crossref: 645] [Cited by in F6Publishing: 661] [Article Influence: 71.7] [Reference Citation Analysis]
125 Chawla A, Huang TL, Ibrahim AM, Hardacre JM, Siegel C, Ammori JB. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer. HPB 2018;20:398-404. [DOI: 10.1016/j.hpb.2017.10.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
126 Racz JM, Cleghorn MC, Jimenez MC, Atenafu EG, Jackson TD, Okrainec A, Venkat Raghavan L, Quereshy FA. Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors. Ann Surg Oncol 2015;22:2343-50. [DOI: 10.1245/s10434-014-4265-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
127 Xu ZS, Zhang FP, Zhang Y, Ou-Yang YP, Yu XW, Wang WL, Xu WJ, Luo ZQ. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis. Oncotarget 2017;8:99003-12. [PMID: 29228745 DOI: 10.18632/oncotarget.20871] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
128 Miyagi T, Miyata S, Tagami K, Hiratsuka Y, Sato M, Takeda I, Kohata K, Satake N, Shimokawa H, Inoue A. Prognostic model for patients with advanced cancer using a combination of routine blood test values. Support Care Cancer 2021;29:4431-7. [PMID: 33443662 DOI: 10.1007/s00520-020-05937-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H. Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer. 2012;107:988-993. [PMID: 22878374 DOI: 10.1038/bjc.2012.354] [Cited by in Crossref: 168] [Cited by in F6Publishing: 179] [Article Influence: 16.8] [Reference Citation Analysis]
130 Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47:2633-2641. [PMID: 21724383 DOI: 10.1016/j.ejca.2011.03.028] [Cited by in Crossref: 424] [Cited by in F6Publishing: 444] [Article Influence: 38.5] [Reference Citation Analysis]
131 Xie X, Luo K, Hu Y, Wang J, Chen J. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer: Preoperative PLR and ESCC outcomes. Dis Esophagus 2016;29:79-85. [DOI: 10.1111/dote.12296] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
132 Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye X, Chen Y, Chen D, Dettke M. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol. 2015;36:9319-9325. [PMID: 26104767 DOI: 10.1007/s13277-015-3667-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
133 Anderson JL, Newman NB, Anderson C, Sherry AD, Yock AD, Osmundson EC. Mean cardiopulmonary dose and vertebral marrow dose differentially predict lineage-specific leukopenia kinetics during radiotherapy for esophageal cancer. Radiother Oncol 2020;152:169-76. [PMID: 32291110 DOI: 10.1016/j.radonc.2019.12.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
134 Zhang H, Xia H, Zhang L, Zhang B, Yue D, Wang C. Clinical significance of preoperative neutrophil–lymphocyte vs platelet–lymphocyte ratio in primary operable patients with non–small cell lung cancer. The American Journal of Surgery 2015;210:526-35. [DOI: 10.1016/j.amjsurg.2015.03.022] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
135 Dertli R, Asil M, Biyik M, Karakarcayildiz A, Keskin M, Göktepe HM, Kayar Y, Ataseven H. Can Hematological Inflammatory Parameters Predict Mortality in Hepatocellular Carcinoma? J Gastrointest Cancer 2021;52:666-75. [PMID: 32617832 DOI: 10.1007/s12029-020-00448-2] [Reference Citation Analysis]
136 Jin D, Tan J, Jiang J, Philips D, Liu L. The early predictive value of routine laboratory tests on the severity of acute pancreatitis patients in pregnancy: a retrospective study. Sci Rep 2020;10:10087. [PMID: 32572085 DOI: 10.1038/s41598-020-66921-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
137 Iwai N, Okuda T, Oka K, Sakagami J, Harada T, Ohara T, Hattori C, Taniguchi M, Sakai H, Hara T, Tsuji T, Komaki T, Kagawa K, Dohi O, Yasuda H, Itoh Y. Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer. Cancers (Basel) 2021;13:3860. [PMID: 34359761 DOI: 10.3390/cancers13153860] [Reference Citation Analysis]
138 Yuan D, Zhu K, Li K, Yan R, Jia Y, Dang C. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J Surg Oncol 2014;110:333-40. [PMID: 24889121 DOI: 10.1002/jso.23651] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
139 Sakamoto T, Saito H, Amisaki M, Tokuyasu N, Honjo S, Fujiwara Y. Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer. Hepatobiliary Pancreat Dis Int 2019;18:278-84. [PMID: 30987900 DOI: 10.1016/j.hbpd.2019.03.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
140 Gunduz S, Mutlu H, Tural D, Yıldız Ö, Uysal M, Coskun HS, Bozcuk H. Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Asia Pac J Clin Oncol 2015;11:288-92. [PMID: 25871569 DOI: 10.1111/ajco.12358] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]
141 Zhou D, Zhang Y, Xu L, Zhou Z, Huang J, Chen M. A monocyte/granulocyte to lymphocyte ratio predicts survival in patients with hepatocellular carcinoma. Sci Rep. 2015;5:15263. [PMID: 26486016 DOI: 10.1038/srep15263] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
142 Açar G, Kalkan ME, Avci A, Alizade E, Tabakci MM, Toprak C, Özkan B, Alici G, Esen AM. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost 2015;21:462-8. [PMID: 24142833 DOI: 10.1177/1076029613508599] [Cited by in Crossref: 24] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
143 Neuzillet C, Sauvanet A, Hammel P. Prognostic factors for resectable pancreatic adenocarcinoma. Journal of Visceral Surgery 2011;148:e232-43. [DOI: 10.1016/j.jviscsurg.2011.07.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
144 Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, Ohsawa M, Kitagawa S, Hirakawa K. Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer. PLoS One 2016;11:e0153459. [PMID: 27472762 DOI: 10.1371/journal.pone.0153459] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
145 Lusho S, Durando X, Mouret-Reynier MA, Kossai M, Lacrampe N, Molnar I, Penault-Llorca F, Radosevic-Robin N, Abrial C. Platelet-to-Lymphocyte Ratio Is Associated With Favorable Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Study on 120 Patients. Front Oncol 2021;11:678315. [PMID: 34367964 DOI: 10.3389/fonc.2021.678315] [Reference Citation Analysis]
146 Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT. The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol. 2014;21:3938-3946. [PMID: 24866438 DOI: 10.1245/s10434-014-3815-2] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 9.3] [Reference Citation Analysis]
147 Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197-203. [PMID: 20122680 DOI: 10.1016/j.amjsurg.2009.08.041] [Cited by in Crossref: 197] [Cited by in F6Publishing: 217] [Article Influence: 16.4] [Reference Citation Analysis]
148 Liberko M, Kolostova K, Szabo A, Gurlich R, Oliverius M, Soumarova R. Circulating Tumor Cells, Circulating Tumor DNA and Other Blood-based Prognostic Scores in Pancreatic Ductal Adenocarcinoma - Mini-Review. In Vivo 2021;35:31-9. [PMID: 33402447 DOI: 10.21873/invivo.12229] [Reference Citation Analysis]
149 Oylumlu M, Oylumlu M, Arslan B, Polat N, Özbek M, Demir M, Yildiz A, Toprak N. Platelet-to-lymphocyte ratio is a predictor of long-term mortality in patients with acute coronary syndrome. Postepy Kardiol Interwencyjnej 2020;16:170-6. [PMID: 32636901 DOI: 10.5114/aic.2020.95859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
150 Hudzik B, Szkodziński J, Korzonek-Szlacheta I, Wilczek K, Gierlotka M, Lekston A, Zubelewicz-Szkodzińska B, Gąsior M. Platelet-to-lymphocyte ratio predicts contrast-induced acute kidney injury in diabetic patients with ST-elevation myocardial infarction. Biomark Med 2017;11:847-56. [PMID: 28976786 DOI: 10.2217/bmm-2017-0120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
151 Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma: Inflammatory Markers in Head and Neck Malignancies. Head Neck 2015;37:103-10. [DOI: 10.1002/hed.23567] [Cited by in Crossref: 87] [Cited by in F6Publishing: 93] [Article Influence: 10.9] [Reference Citation Analysis]
152 Kim SM, Kim EH, Kim BH, Kim JH, Park SB, Nam YJ, Ahn KH, Oh MY, Kim WJ, Jeon YK, Kim SS, Kim YK, Kim IJ. Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer. Endocrinol Metab (Seoul) 2015;30:494-501. [PMID: 26354491 DOI: 10.3803/EnM.2015.30.4.494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
153 Marchi F, Missale F, Incandela F, Filauro M, Mazzola F, Mora F, Paderno A, Parrinello G, Piazza C, Peretti G. Prognostic Significance of Peripheral T-Cell Subsets in Laryngeal Squamous Cell Carcinoma. Laryngoscope Investig Otolaryngol 2019;4:513-9. [PMID: 31637295 DOI: 10.1002/lio2.304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
154 Luo Z, Zhou L, Balde AI, Li Z, He L, ZhenWei C, Zou Z, Huang S, Han S, Wei Zhou M, Zhang GQ, Cai Z. Prognostic impact of preoperative prognostic nutritional index in resected advanced gastric cancer: A multicenter propensity score analysis. Eur J Surg Oncol 2019;45:425-31. [PMID: 30366877 DOI: 10.1016/j.ejso.2018.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
155 Hudzik B, Szkodziński J, Lekston A, Gierlotka M, Poloński L, Gąsior M. Mean platelet volume-to-lymphocyte ratio: a novel marker of poor short- and long-term prognosis in patients with diabetes mellitus and acute myocardial infarction. J Diabetes Complications 2016;30:1097-102. [PMID: 27138871 DOI: 10.1016/j.jdiacomp.2016.04.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
156 Li X, Chen ZH, Ma XK, Chen J, Wu DH, Lin Q, Dong M, Wei L, Wang TT, Ruan DY. Neutrophil-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma. Tumour Biol. 2014;35:11057-11063. [PMID: 25095975 DOI: 10.1007/s13277-014-2360-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
157 Tang F, Dai P, Wei Q, Gan K, Wang Z, Chen H, Li T, Lv M, Deng M, Luo G. The Neutrophil-to-Monocyte Ratio and Platelet-to-White Blood Cell Ratio Represent Novel Prognostic Markers in Patients with Pancreatic Cancer. Gastroenterol Res Pract 2021;2021:6693028. [PMID: 34122538 DOI: 10.1155/2021/6693028] [Reference Citation Analysis]
158 Tabata N, Al-Kassou B, Sugiura A, Shamekhi J, Treede H, Ishii M, Tsujita K, Werner N, Grube E, Nickenig G, Sinning JM. Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement. JACC CardioOncol 2019;1:159-69. [PMID: 34396177 DOI: 10.1016/j.jaccao.2019.10.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Ozawa T, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Hata K, Kawai K, Nozawa H, Kazama S. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer. Int J Colorectal Dis. 2015;30:1165-1171. [PMID: 26049902 DOI: 10.1007/s00384-015-2276-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
160 Mori M, Shuto K, Kosugi C, Narushima K, Hayashi H, Matsubara H, Koda K. An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer. BMC Cancer 2018;18:1261. [PMID: 30558575 DOI: 10.1186/s12885-018-5171-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
161 Khoury T, Mahamid M, Lubany A, Safadi M, Farah A, Sbeit W, Mari A. Underlying Colorectal Cancer Was Rarely Detected After an Episode of Acute Diverticulitis: a Retrospective Analysis of 225 Patients. J Gastrointest Cancer 2020;51:48-52. [PMID: 30632029 DOI: 10.1007/s12029-019-00202-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
162 Imaoka H, Mizuno N, Hara K, Hijioka S, Tajika M, Tanaka T, Ishihara M, Yogi T, Tsutsumi H, Fujiyoshi T, Sato T, Shimizu Y, Niwa Y, Yamao K. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study. Pancreas 2016;45:211-7. [PMID: 26495775 DOI: 10.1097/MPA.0000000000000446] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
163 Martin HL, Ohara K, Kiberu A, Van Hagen T, Davidson A, Khattak MA. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J. 2014;44:676-682. [PMID: 24750233 DOI: 10.1111/imj.12453] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
164 Ahiko Y, Shida D, Nakamura Y, Imaizumi J, Takamizawa Y, Moritani K, Tsukamoto S, Kanemitsu Y. Preoperative Nutritional Scores as Host-Related Prognostic Factors for Both Overall Survival and Postoperative Complications in Stage II - III Colorectal Cancer Patients. Dis Colon Rectum 2021. [PMID: 33951689 DOI: 10.1097/DCR.0000000000002033] [Reference Citation Analysis]
165 Tural Onur S, Sokucu SN, Dalar L, Iliaz S, Kara K, Buyukkale S, Altin S. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma? Ther Clin Risk Manag 2016;12:651-6. [PMID: 27217757 DOI: 10.2147/TCRM.S104077] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
166 Tominaga T, Nonaka T, Sumida Y, Hidaka S, Sawai T, Nagayasu T. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients. PLoS One 2016;11:e0167967. [PMID: 27930703 DOI: 10.1371/journal.pone.0167967] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
167 Iseda N, Itoh S, Yoshizumi T, Tomiyama T, Morinaga A, Shimagaki T, Wang H, Kurihara T, Toshima T, Nagao Y, Harada N, Oda Y, Mori M. Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma. Int J Clin Oncol 2021. [PMID: 34251555 DOI: 10.1007/s10147-021-01985-x] [Reference Citation Analysis]
168 Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. J Gastrointest Surg. 2020;24:610-618. [PMID: 30923999 DOI: 10.1007/s11605-019-04187-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 10.7] [Reference Citation Analysis]
169 Morizane S, Iwamoto H, Yao A, Isoyama T, Sejima T, Takenaka A. Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin - preliminary results. Cent European J Urol 2012;65:62-6. [PMID: 24578930 DOI: 10.5173/ceju.2012.02.art1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
170 He W, Wei M, Yang X, Chen B, Wu Q, Zheng E, Deng X, Wang Z. Do inflammatory markers predict prognosis in patients with synchronous colorectal cancer? Medicine (Baltimore) 2017;96:e6607. [PMID: 28445257 DOI: 10.1097/MD.0000000000006607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 2011;104:1288-95. [PMID: 21448173 DOI: 10.1038/bjc.2011.100] [Cited by in Crossref: 272] [Cited by in F6Publishing: 275] [Article Influence: 24.7] [Reference Citation Analysis]
172 Seong MK. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer. J Korean Med Sci 2015;30:1793-9. [PMID: 26713054 DOI: 10.3346/jkms.2015.30.12.1793] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
173 Gonda K, Shibata M, Sato Y, Washio M, Takeshita H, Shigeta H, Ogura M, Oka S, Sakuramoto S. Elevated neutrophil-to-lymphocyte ratio is associated with nutritional impairment, immune suppression, resistance to S-1 plus cisplatin, and poor prognosis in patients with stage IV gastric cancer. Mol Clin Oncol. 2017;7:1073-1078. [PMID: 29285377 DOI: 10.3892/mco.2017.1438] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
174 Ceylan Y, Kumanlıoğlu K, Oral A, Ertan Y, Özcan Z. The Correlation of Clinicopathological Findings and Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma. Mol Imaging Radionucl Ther 2019;28:15-20. [PMID: 30942057 DOI: 10.4274/mirt.galenos.2018.60490] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
175 Zhu S, Miao CW, Wang ZT, Peng L, Li B. Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma. Onco Targets Ther 2016;9:6187-93. [PMID: 27789959 DOI: 10.2147/OTT.S115011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
176 Brenner DR, Scherer D, Muir K, Schildkraut J, Boffetta P, Spitz MR, Le Marchand L, Chan AT, Goode EL, Ulrich CM, Hung RJ. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prev 2014;23:1729-51. [PMID: 24962838 DOI: 10.1158/1055-9965.EPI-14-0064] [Cited by in Crossref: 71] [Cited by in F6Publishing: 33] [Article Influence: 8.9] [Reference Citation Analysis]
177 Mo CJ, Hu ZJ, Qin SZ, Chen HP, Huang L, Li S, Cao Z. Diagnostic value of platelet-lymphocyte ratio and hemoglobin-platelet ratio in patients with rectal cancer. J Clin Lab Anal 2020;34:e23153. [PMID: 31960471 DOI: 10.1002/jcla.23153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
178 Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Matsunaga Y, Shiihara M, Yamamoto M. Evaluation of the significance of adjuvant chemotherapy in patients with stage ⅠA pancreatic ductal adenocarcinoma. Pancreatology 2021;21:581-8. [PMID: 33579600 DOI: 10.1016/j.pan.2021.01.024] [Reference Citation Analysis]
179 Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu J, Yue D, Zhang B, Wang C. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study. PLoS One 2015;10:e0126496. [PMID: 25950176 DOI: 10.1371/journal.pone.0126496] [Cited by in Crossref: 45] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
180 Hu W, Yu J, Huang Y, Hu F, Zhang X, Wang Y. Lymphocyte-Related Inflammation and Immune-Based Scores Predict Prognosis of Chordoma Patients After Radical Resection. Transl Oncol. 2018;11:444-449. [PMID: 29477108 DOI: 10.1016/j.tranon.2018.01.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
181 Akdag S, Akyol A, Asker M, Ozturk F, Gumrukcuoglu HA. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with non-ST segment elevation myocardial infarction. Postepy Kardiol Interwencyjnej 2016;12:224-30. [PMID: 27625685 DOI: 10.5114/aic.2016.61644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
182 Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S. Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients. Cancers (Basel). 2019;11. [PMID: 30974894 DOI: 10.3390/cancers11040514] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
183 Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, Yıldız B, Yıldırım N, Demirci U, Sendur MA, Utkan G, Kılıckap S, Cicin I, Karadurmus N, Ürün Y. The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. J Oncol Pharm Pract 2020;26:1110-6. [DOI: 10.1177/1078155219883004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
184 Yang C, Jiang H, Huang S, Hong H, Huang X, Wang X, Liao W, Wang X, Chen X, Jiang L. The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis. Medicine (Baltimore). 2018;97:e11763. [PMID: 30075601 DOI: 10.1097/md.0000000000011763] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
185 Vashist YK, Loos J, Dedow J, Tachezy M, Uzunoglu G, Kutup A, Yekebas EF, Izbicki JR. Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol. 2011;18:1130-1138. [PMID: 20981494 DOI: 10.1245/s10434-010-1383-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
186 Alagappan M, Pollom EL, von Eyben R, Kozak MM, Aggarwal S, Poultsides GA, Koong AC, Chang DT. Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT. Am J Clin Oncol. 2018;41:242-247. [PMID: 26757436 DOI: 10.1097/coc.0000000000000263] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
187 Tominaga T, Takeshita H, Takagi K, Kunizaki M, To K, Abo T, Hidaka S, Nanashima A, Nagayasu T, Sawai T. E-PASS score as a useful predictor of postoperative complications and mortality after colorectal surgery in elderly patients. Int J Colorectal Dis 2016;31:217-25. [DOI: 10.1007/s00384-015-2456-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
188 Yanagiya M, Nitadori JI, Nagayama K, Anraku M, Sato M, Nakajima J. Prognostic significance of the preoperative neutrophil-to-lymphocyte ratio for complete resection of thymoma. Surg Today 2018;48:422-30. [PMID: 29063371 DOI: 10.1007/s00595-017-1602-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
189 Taşoğlu İ, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost 2014;20:645-50. [PMID: 23393289 DOI: 10.1177/1076029613475474] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
190 Okumura S, Kaido T, Hamaguchi Y, Fujimoto Y, Masui T, Mizumoto M, Hammad A, Mori A, Takaori K, Uemoto S. Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery. 2015;157:1088-1098. [PMID: 25799468 DOI: 10.1016/j.surg.2015.02.002] [Cited by in Crossref: 123] [Cited by in F6Publishing: 116] [Article Influence: 17.6] [Reference Citation Analysis]
191 Liu D, Huang Y, Li L, Song J, Zhang L, Li W. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer. BMC Cancer 2017;17:882. [PMID: 29268698 DOI: 10.1186/s12885-017-3893-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
192 Li MX, Liu XM, Zhang XF, Zhang JF, Wang WL, Zhu Y, Dong J, Cheng JW, Liu ZW, Ma L, Lv Y. Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2014;134:2403-2413. [PMID: 24122750 DOI: 10.1002/ijc.28536] [Cited by in Crossref: 241] [Cited by in F6Publishing: 257] [Article Influence: 30.1] [Reference Citation Analysis]
193 Nesseler JP, Schaue D, McBride WH, Nickers P. [Inflammatory and immune biomarkers of radiation response]. Cancer Radiother 2018;22:180-92. [PMID: 29650389 DOI: 10.1016/j.canrad.2017.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
194 Zhao J, Chen Y, Wang J, Wang J, Wang Y, Chai S, Zhang Y, Chen X, Zhang W. Preoperative risk grade predicts the long-term prognosis of intrahepatic cholangiocarcinoma: a retrospective cohort analysis. BMC Surg 2021;21:113. [PMID: 33676467 DOI: 10.1186/s12893-020-00954-x] [Reference Citation Analysis]
195 Hudzik B, Szkodzinski J, Gorol J, Niedziela J, Lekston A, Gasior M, Polonski L. Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction. Biomarkers in Medicine 2015;9:199-207. [DOI: 10.2217/bmm.14.100] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
196 Song X, Zhang GM, Ma XC, Luo L, Li B, Chai DY, Sun LJ. Comparison of preoperative neutrophil-lymphocyte, lymphocyte-monocyte, and platelet-lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy. Onco Targets Ther 2016;9:1399-407. [PMID: 27042108 DOI: 10.2147/OTT.S97520] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
197 Cummings M, Merone L, Keeble C, Burland L, Grzelinski M, Sutton K, Begum N, Thacoor A, Green B, Sarveswaran J, Hutson R, Orsi NM. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival. Br J Cancer 2015;113:311-20. [PMID: 26079303 DOI: 10.1038/bjc.2015.200] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
198 Mohamed Z, Pinato DJ, Mauri FA, Chen KW, Chang PM, Sharma R. Inflammation as a validated prognostic determinant in carcinoma of unknown primary site. Br J Cancer 2014;110:208-13. [PMID: 24169348 DOI: 10.1038/bjc.2013.683] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
199 Shirai Y, Shiba H, Sakamoto T, Horiuchi T, Haruki K, Fujiwara Y, Futagawa Y, Ohashi T, Yanaga K. Preoperative platelet to lymphocyte ratio predicts outcome of patients with pancreatic ductal adenocarcinoma after pancreatic resection. Surgery. 2015;158:360-365. [PMID: 26032829 DOI: 10.1016/j.surg.2015.03.043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 6.3] [Reference Citation Analysis]
200 Hasegawa S, Eguchi H, Tomokuni A, Tomimaru Y, Asaoka T, Wada H, Hama N, Kawamoto K, Kobayashi S, Marubashi S, Konnno M, Ishii H, Mori M, Doki Y, Nagano H. Pre-treatment neutrophil to lymphocyte ratio as a predictive marker for pathological response to preoperative chemoradiotherapy in pancreatic cancer. Oncol Lett 2016;11:1560-6. [PMID: 26893780 DOI: 10.3892/ol.2015.4057] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
201 Raffetti E, Donato F, Pezzoli C, Digiambenedetto S, Bandera A, Di Pietro M, Di Filippo E, Maggiolo F, Sighinolfi L, Fornabaio C, Castelnuovo F, Ladisa N, Castelli F, Quiros Roldan E. Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject With Solid Cancer in an Italian Multicenter Study. J Acquir Immune Defic Syndr 2015;69:585-92. [PMID: 26167619 DOI: 10.1097/QAI.0000000000000682] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
202 Lim JU, Yeo CD, Kang HS, Park CK, Kim JS, Kim JW, Kim SJ, Lee SH. Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion. Sci Rep 2019;9:4721. [PMID: 30886226 DOI: 10.1038/s41598-019-41289-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
203 Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol. 2012;29:3092-3100. [PMID: 22476808 DOI: 10.1007/s12032-012-0226-8] [Cited by in Crossref: 125] [Cited by in F6Publishing: 138] [Article Influence: 12.5] [Reference Citation Analysis]
204 Sambel M, Kilic M, Demirbas M, Onen E, Oner S, Erdogan A, Aydos MM. Relationship between erectile dysfunction and the neutrophil to lymphocyte and platelet to lymphocyte ratios. Int J Impot Res 2018;30:27-35. [DOI: 10.1038/s41443-017-0007-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
205 Hu CH, Yeh CN, Chen JS, Tsai CY, Wang SY, Cheng CT, Yeh TS. Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study. Oncol Lett 2020;20:2131-42. [PMID: 32782530 DOI: 10.3892/ol.2020.11756] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
206 Fox P, Hudson M, Brown C, Lord S, Gebski V, De Souza P, Lee CK. Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer. 2013;109:147-153. [PMID: 23778526 DOI: 10.1038/bjc.2013.300] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 10.3] [Reference Citation Analysis]
207 Keskin S, Keskin Z, Taskapu HH, Kalkan H, Kaynar M, Poyraz N, Toy H. Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma. BMC Urol 2014;14:95. [PMID: 25427576 DOI: 10.1186/1471-2490-14-95] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
208 Abe A, Hayashi H, Ishihama T, Furuta H. Prognostic impact of the prognostic nutritional index in cases of resected oral squamous cell carcinoma: a retrospective study. BMC Oral Health 2021;21:40. [PMID: 33482792 DOI: 10.1186/s12903-021-01394-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
209 Zhang X, Zhao W, Yu Y, Qi X, Song L, Zhang C, Li G, Yang L. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis. World J Surg Oncol 2020;18:191. [PMID: 32731872 DOI: 10.1186/s12957-020-01952-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
210 Que Y, Qiu H, Li Y, Chen Y, Xiao W, Zhou Z, Zhang X. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma. BMC Cancer 2015;15:648. [PMID: 26432433 DOI: 10.1186/s12885-015-1654-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
211 Tatar E, Mirili C, Isikyakar T, Yaprak M, Guvercin G, Ozay E, Asci G. The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clinica Belgica 2016;71:221-6. [DOI: 10.1080/17843286.2016.1159797] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
212 Fang S, Suzuki K, Lim CL, Chung M, Ku P, Chen L. Associations between sleep quality and inflammatory markers in patients with schizophrenia. Psychiatry Research 2016;246:154-60. [DOI: 10.1016/j.psychres.2016.09.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
213 Wang W, Bian C, Xia D, He JX, Hai P, Zhao R, Wang YY. Combining Carcinoembryonic Antigen and Platelet to Lymphocyte Ratio to Predict Brain Metastasis of Resected Lung Adenocarcinoma Patients. Biomed Res Int 2017;2017:8076384. [PMID: 28642881 DOI: 10.1155/2017/8076384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
214 Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg 2008;12:1422-8. [PMID: 18543046 DOI: 10.1007/s11605-008-0554-3] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
215 Huang C, Yang Y, Wang K, Chen T, Chen J, Weng C, Chien H, Chang C. Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer. Taiwanese Journal of Obstetrics and Gynecology 2016;55:405-9. [DOI: 10.1016/j.tjog.2016.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
216 Yang J, Guo X, Wang M, Ma X, Ye X, Lin P. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Sci Rep 2017;7:17166. [PMID: 29215037 DOI: 10.1038/s41598-017-17130-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
217 Wang F, Liu ZY, Xia YY, Zhou C, Shen XM, Li XL, Han SG, Zheng Y, Mao ZQ, Gong FR. Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett. 2015;10:3411-3418. [PMID: 26788143 DOI: 10.3892/ol.2015.3783] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
218 Tominaga T, Nonaka T, Takeshita H, Kunizaki M, Sumida Y, Hidaka S, Sawai T, Nagayasu T. The Charlson Comorbidity Index as an Independent Prognostic Factor in Older Colorectal Cancer Patients. Indian J Surg 2018;80:54-60. [PMID: 29581686 DOI: 10.1007/s12262-016-1544-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
219 Uemura K, Kawahara T, Yamashita D, Jikuya R, Abe K, Tatenuma T, Yokomizo Y, Izumi K, Teranishi JI, Makiyama K, Yumura Y, Kishida T, Udagawa K, Kobayashi K, Miyoshi Y, Yao M, Uemura H. Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Castration-Resistant Prostate Cancer Patients Who Received Cabazitaxel Chemotherapy. Biomed Res Int 2017;2017:7538647. [PMID: 28948170 DOI: 10.1155/2017/7538647] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
220 Gao M, Gao Y. Value of preoperative neutrophil-lymphocyte ratio and human epididymis protein 4 in predicting lymph node metastasis in endometrial cancer patients. J Obstet Gynaecol Res 2021;47:515-20. [PMID: 33142358 DOI: 10.1111/jog.14542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
221 Aliustaoglu M, Bilici A, Ustaalioglu BB, Konya V, Gucun M, Seker M, Gumus M. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol. 2010;27:1060-1065. [PMID: 19847679 DOI: 10.1007/s12032-009-9335-4] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 6.1] [Reference Citation Analysis]
222 Vivaldi C, Caparello C, Musettini G, Pasquini G, Catanese S, Fornaro L, Lencioni M, Falcone A, Vasile E. First-line treatment with FOLFOXIRI for advanced pancreatic cancer in clinical practice: Patients' outcome and analysis of prognostic factors. Int J Cancer. 2016;139:938-945. [PMID: 27038273 DOI: 10.1002/ijc.30125] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
223 He YF, Luo HQ, Wang W, Chen J, Yao YW, Yan Y, Wu SS, Hu XX, Ke LH, Niu JY, Li HM, Ji CS, Hu B. Preoperative NLR and PLR in the middle or lower ESCC patients with radical operation. Eur J Cancer Care (Engl) 2017;26. [PMID: 26947428 DOI: 10.1111/ecc.12445] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
224 Kozak MM, von Eyben R, Pai JS, Anderson EM, Welton ML, Shelton AA, Kin C, Koong AC, Chang DT. The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer. Am J Clin Oncol. 2015; Epub ahead of print. [PMID: 25756348 DOI: 10.1097/coc.0000000000000183] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
225 Ural ÜM, Şehitoğlu İ, Tekin YB, Şahin FK. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in patients with endometrial hyperplasia and endometrial cancer. J Obstet Gynaecol Res 2015;41:445-8. [PMID: 25363740 DOI: 10.1111/jog.12536] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
226 Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Medicine (Baltimore) 2016;95:e3582. [PMID: 27149487 DOI: 10.1097/MD.0000000000003582] [Cited by in Crossref: 54] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
227 Chua W, Clarke SJ, Charles KA. Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer. Support Care Cancer 2012;20:1869-74. [PMID: 21986674 DOI: 10.1007/s00520-011-1289-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
228 Nwokediuko SC, Ibegbulam O. Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease. Gastroenterology Res 2009;2:344-9. [PMID: 27990204 DOI: 10.4021/gr2009.12.1329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
229 Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine (Baltimore) 2015;94:e1486. [PMID: 26356714 DOI: 10.1097/MD.0000000000001486] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
230 Dajani K, O'Reilly DA, Carino NL, Ghaneh P, Poston G, Wu A. The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg 2009;2009:425065. [PMID: 19750237 DOI: 10.1155/2009/425065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
231 Zhu M, Feng M, He F, Han B, Ma K, Zeng X, Liu Z, Liu X, Li J, Cao H, Liang Y, Jia C, Zhang L. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Clin Chim Acta 2018;483:296-302. [PMID: 29758203 DOI: 10.1016/j.cca.2018.05.025] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
232 Wang Y, Sun K, Shen J, Li B, Kuang M, Cao Q, Peng S. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy. Cancer Res Treat 2019;51:1464-78. [PMID: 30913869 DOI: 10.4143/crt.2018.657] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
233 Liang Y, Zheng G, Yin W, Song H, Li C, Tian L, Yang D. Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma. Gastroenterol Res Pract 2019;2019:7103915. [PMID: 30863440 DOI: 10.1155/2019/7103915] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
234 Portale G, Cavallin F, Valdegamberi A, Frigo F, Fiscon V. Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio Are Not Prognostic Biomarkers in Rectal Cancer Patients with Curative Resection. J Gastrointest Surg 2018;22:1611-8. [PMID: 29687424 DOI: 10.1007/s11605-018-3781-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
235 Cho U, Park HS, Im SY, Yoo CY, Jung JH, Suh YJ, Choi HJ. Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer. PLoS One 2018;13:e0200936. [PMID: 30048474 DOI: 10.1371/journal.pone.0200936] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 9.3] [Reference Citation Analysis]
236 Zhang H, Gao L, Zhang B, Zhang L, Wang C. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep 2016;6:22618. [PMID: 26939789 DOI: 10.1038/srep22618] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
237 Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma. Crit Rev Oncol Hematol 2016;98:309-24. [PMID: 26653573 DOI: 10.1016/j.critrevonc.2015.11.016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
238 Messager M, Neofytou K, Chaudry MA, Allum WH. Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. Eur J Surg Oncol 2015;41:1316-23. [PMID: 26166786 DOI: 10.1016/j.ejso.2015.06.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
239 Pozza A, Pauletti B, Scarpa M, Ruffolo C, Bassi N, Massani M. Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with midgut neuroendocrine tumors undergoing resective surgery. Int J Colorectal Dis 2019;34:1849-56. [PMID: 31520198 DOI: 10.1007/s00384-019-03356-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
240 Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014;110:2524-30. [PMID: 24675383 DOI: 10.1038/bjc.2014.163] [Cited by in Crossref: 135] [Cited by in F6Publishing: 140] [Article Influence: 16.9] [Reference Citation Analysis]
241 Shen SL, Fu SJ, Chen B, Kuang M, Li SQ, Hua YP, Liang LJ, Guo P, Hao Y, Peng BG. Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resection. Ann Surg Oncol. 2014;21:3802-3809. [PMID: 24849520 DOI: 10.1245/s10434-014-3771-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
242 Zhou DS, Xu L, Luo YL, He FY, Huang JT, Zhang YJ, Chen MS. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World J Gastroenterol 2015; 21(18): 5582-5590 [PMID: 25987783 DOI: 10.3748/wjg.v21.i18.5582] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
243 Ida M, Tachiiri Y, Sato M, Kawaguchi M. Neutrophil‐to‐lymphocyte ratio as indicator to severe complication after pancreaticoduodenectomy or distal pancreatectomy. Acta Anaesthesiol Scand 2019;63:739-44. [DOI: 10.1111/aas.13341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
244 Zhang L, Su Y, Chen Z, Wei Z, Han W, Xu A. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine (Baltimore) 2017;96:e7647. [PMID: 28746229 DOI: 10.1097/MD.0000000000007647] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 3.2] [Reference Citation Analysis]
245 Mowbray NG, Griffith D, Hammoda M, Shingler G, Kambal A, Al-Sarireh B. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection. HPB (Oxford) 2018;20:379-84. [PMID: 29336893 DOI: 10.1016/j.hpb.2017.12.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
246 Tingle SJ, Severs GR, Goodfellow M, Moir JA, White SA. NARCA: A novel prognostic scoring system using neutrophil-albumin ratio and Ca19-9 to predict overall survival in palliative pancreatic cancer. J Surg Oncol 2018;118:680-6. [PMID: 30196571 DOI: 10.1002/jso.25209] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
247 Oylumlu M, Doğan A, Oylumlu M, Yıldız A, Yüksel M, Kayan F, Kilit C, Amasyalı B. Relationship between platelet-to-lymphocyte ratio and coronary slow flow. Anatol J Cardiol 2015;15:391-5. [PMID: 25430406 DOI: 10.5152/akd.2014.5376] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
248 Wang Y, Attar BM, Fuentes HE, Jaiswal P, Tafur AJ. Evaluation of the prognostic value of platelet to lymphocyte ratio in patients with hepatocellular carcinoma. J Gastrointest Oncol 2017;8:1065-71. [PMID: 29299368 DOI: 10.21037/jgo.2017.09.06] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
249 Ozgonul C, Sertoglu E, Mumcuoglu T, Ozge G, Gokce G. Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio. Ocul Immunol Inflamm 2016;24:665-70. [PMID: 26645794 DOI: 10.3109/09273948.2015.1063671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
250 Asari S, Matsumoto I, Toyama H, Shinzeki M, Goto T, Ishida J, Ajiki T, Fukumoto T, Ku Y. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios. Surg Today 2016;46:583-92. [DOI: 10.1007/s00595-015-1206-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
251 Witte HM, Bonorden B, Riecke A, Biersack H, Steinestel K, Merz H, Feller AC, Bernard V, Fetscher S, von Bubnoff N, Gebauer N. The Glasgow Prognostic Score at Diagnosis Is a Predictor of Clinical Outcome in Patients with Multiple Myeloma Undergoing Autologous Haematopoietic Stem Cell Transplantation. Cancers (Basel) 2020;12:E921. [PMID: 32283706 DOI: 10.3390/cancers12040921] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
252 Song JE, Lee KY, Son GH. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio for Repeat Cerclage in Women with Prolapsed Membranes. Biomed Res Int 2018;2018:1507398. [PMID: 30410922 DOI: 10.1155/2018/1507398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Jamieson NB, Denley SM, Logue J, MacKenzie DJ, Foulis AK, Dickson EJ, Imrie CW, Carter R, McKay CJ, McMillan DC. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2011;18:2318-2328. [PMID: 21267785 DOI: 10.1245/s10434-011-1560-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
254 Agizamhan S, Qu F, Liu N, Sun J, Xu W, Zhang L, Guo H, Gan W. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients. BMC Urol 2018;18:60. [PMID: 29890986 DOI: 10.1186/s12894-018-0374-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
255 Ahn Y, Ahn HJ, Yoon DH, Hong JY, Yoo C, Kim S, Huh J, Suh C. Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology. Blood Res 2017;52:285-92. [PMID: 29333405 DOI: 10.5045/br.2017.52.4.285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
256 Roxburgh CS, Wallace AM, Guthrie GK, Horgan PG, McMillan DC. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative surgery for colon cancer. Colorectal Dis 2010;12:987-94. [PMID: 19555389 DOI: 10.1111/j.1463-1318.2009.01961.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
257 Dang C, Wang M, Zhu F, Qin T, Qin R. Controlling nutritional status (CONUT) score-based nomogram to predict overall survival of patients with pancreatic cancer undergoing radical surgery. Asian J Surg 2021:S1015-9584(21)00513-3. [PMID: 34493426 DOI: 10.1016/j.asjsur.2021.08.011] [Reference Citation Analysis]
258 Huang GQ, Zheng JN, Zou TT, Chen YR, Shi KQ, Poucke SV, Cheng Z, Ruan LY, Zheng MH. Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection. J Clin Transl Hepatol 2017;5:35-42. [PMID: 28507925 DOI: 10.14218/JCTH.2016.00035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
259 Fu YP, Ni XC, Yi Y, Cai XY, He HW, Wang JX, Lu ZF, Han X, Cao Y, Zhou J, Fan J, Qiu SJ. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article. Medicine (Baltimore) 2016;95:e2784. [PMID: 26886627 DOI: 10.1097/MD.0000000000002784] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
260 Domínguez I, Fernández-del Castillo C. Preoperative platelet-lymphocyte ratio in resected pancreatic ductal carcinoma: is it meaningful? Am J Surg 2012;203:412. [PMID: 20579970 DOI: 10.1016/j.amjsurg.2009.05.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
261 Selen S, Kilic F, Kimyon Comert G, Unsal M, Kilic C, Karalok A, Turkmen O, Turan T. Can preoperative inflammatory markers differentiate endometrial cancer from complex atypical hyperplasia/endometrial intraepithelial neoplasia? J Obstet Gynaecol Res 2020;46:1148-56. [PMID: 32464701 DOI: 10.1111/jog.14314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
262 Chen S, Guo J, Feng C, Ke Z, Chen L, Pan Y. The preoperative platelet-lymphocyte ratio versus neutrophil-lymphocyte ratio: which is better as a prognostic factor in oral squamous cell carcinoma? Ther Adv Med Oncol 2016;8:160-7. [PMID: 27239234 DOI: 10.1177/1758834016638019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 6.3] [Reference Citation Analysis]
263 Aktekin A, Torun M, Ustaalioğlu BBO, Ozkara S, Cakır O, Muftuoglu T. The effects of systemic inflammatory response on prognosis of pancreatic ductal adenocarcinoma. Ann Hepatobiliary Pancreat Surg 2019;23:155-62. [PMID: 31225417 DOI: 10.14701/ahbps.2019.23.2.155] [Reference Citation Analysis]
264 Strijker M, Chen JW, Mungroop TH, Jamieson NB, van Eijck CH, Steyerberg EW, Wilmink JW, Groot Koerkamp B, van Laarhoven HW, Besselink MG. Systematic review of clinical prediction models for survival after surgery for resectable pancreatic cancer. Br J Surg 2019;106:342-54. [PMID: 30758855 DOI: 10.1002/bjs.11111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]